Artificial urinary sphincters
€12.5M Series B from
← All transactions
UroMems: €23M Series B extension from btov, Financière Arbevel, Bpifrance, HIL-INVENT, Wellington Partners, Supernova Invest
Exclusive advisor to the company
- Date
- Apr 2021
- Sector
- Healthcare
- Business
- Artificial urinary sphincters
- Transaction
- €23M Series B extension from btov, Financière Arbevel, Bpifrance, HIL-INVENT, Wellington Partners, Supernova Invest
- Apparius’s role
- Exclusive advisor to the company
- Area of focus
- Medical devices
UroMems closed the second tranche of its Series B with its existing investors to reach a key milestone: the first human implantation of its artificial urinary sphincter, the first implantable mechatronic device to treat incontinence.
Other transactions with UroMems
Urology
€12M Series B from
